Indications & Usage
Apply the EVOBEAUTY Leave-in Minoxidil 1% on wet or dry hair. Do not rinse out and style as usual.
Hair Leave In Cream
FDA Label NDC 87022-010
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Laboratorio Mk Srl for the product Hair Leave In (NDC 87022-010). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding indications & usage, inactive ingredient, warnings, information for owners/caregivers, dosage & administration, otc - keep out of reach of children, otc - purpose, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
Water, Myristyl Alcohol, Behentrimonium METHOSULFATE (and) Cetearyl Alcohol, Cyclopentasiloxane, Cetyl Alcohol, Hydroxycetyl Hydroxyethyl Dimonium Chloride, Isopropyl Myristate, Glycerin, Decyl Oleate, Polyquaternium-7, Ginger Root Extract, Peppermint Extract, Citric Acid, Benzyl Alcohol (and) Methylchloroisothiazolinone (and) Methylisothiazolinone
Warnings
Avoid eye contact, if occurs rinse eyes thoroughly with water. If develop any allergic reaction, discontinue its use.
Information For Owners/Caregivers
Customer Service USA (917)508-6002
Customer Service RD (809)379-0900
www.mkcosmeticos.com
Dosage & Administration
Apply the EVOBEAUTY Leave-in Minoxidil 1% on wet or dry hair. Do not rinse out and style as usual.
Otc - Keep Out Of Reach Of Children
Keep out reach of children. For external use only.
Otc - Purpose
growth and help prevent hair and beard loss. Revitalizes hair follicles and stimulates growth.
Package Label.Principal Display Panel
This is the principal panel display side of the minoxidil hair leave in 1%.
* Please review the disclaimer below.
